China Fluoxetine Market, 2010-2019
•
1 like•975 views
There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRIs survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%
Recommended
Recommended
More Related Content
Recently uploaded
Recently uploaded (20)
Featured
Featured (20)
China Fluoxetine Market, 2010-2019
- 1. China Fluoxetine Market, 2010-2019 There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRIs survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%. Report Code : 1602320 Published : Feb-2016 Pages : 20
- 2. China Fluoxetine Market • Every year, the suicide death toll of depression around the world is up to 1 million people and the amount of depression patients in China has reached 90 million. • At present, the recognition rate of depression in our country is only 30% and the identified patients seeking medical advice is also 30%, which means less than 10% of the depressive patients were likely to utilize medical service. • Clinical experience shows that 80% of the patients can achieve clinical cure, if having standard treatment, expect very few patients with refractory type, others will be improvement.
- 3. China Fluoxetine Market • Original antidepressants Fluoxetine produced by Eli Lilly and Company was approved for the treatment of depression first in Belgium in 1986. • Fluoxetine is a kind of selective serotonin reuptake inhibitors (SSRI) antidepressants and its medicinal form is Fluoxetine hydrochloride. • Eli Lilly and Company named their products "the optimal solution" (Prozac) which is used for the treatment of adult depression, obsessive-compulsive disorder and neurological bulimia in clinical practice as well as panic disorder with or without agoraphobe.
- 4. China Fluoxetine Market • At the end of 1987, Fluoxetine was approved by the U.S. Food and Drug Administration (FDA) to enter American market, and it entered the Chinese market on March 30, 1995. • Eli Lilly and Companys patent for Prozac expired in August of 2001, since then there have appeared a large number of Fluoxetine drugs on the market. • There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRIs survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%.
- 5. China Fluoxetine Market • Eli Lilly and Company (Spain), Eli Lilly and Company (Britain), Patheon (FR), Shanghai Zhongxi Pharmaceutical Co., Ltd, Changzhou Siyao Pharmaceutical Co., Ltd, SCCPC, WATSON Pharmaceuticals (Changzhou) Co., Ltd and Shanxi C&Y Pharmaceutical Group Co., Ltd. occupy large portion in the sales market. Measured by sales value, Lilly (Spain) enjoyed the highest market share, which reached 75% in 2014. • In China, with many people bearing a proliferation of pressure from life, learning and work, the amount of depressive patients will also present an increasing tendency. In conclusion, there exists huge potential in Chinese market demand for Fluoxetine.
- 6. Charts in report • Chart Patent Status of Fluoxetine in China • Chart Approval Information of Fluoxetine in China • Chart Sales Situation of Fluoxetine in China • Chart Sales Value of Fluoxetine in China, 2010-2014 • Chart Sales Value of Fluoxetine in Some Regions of China, 2010-2014 • Chart Sales Volume of Fluoxetine in China, 2010-2014 • Chart Market Share of Corporations of TOP5 Fluoxetine Sales Value in China, 2010-2014 • Chart Sales Value and Market Share of Fluoxetine Produced by Eli Lilly and Company (Spain), 2010-2014
- 7. Charts in report • Chart Sales Value and Market Share of Fluoxetine Produced by Eli Lilly and Company (Britain), 2010-2014 • Chart Sales Value and Market Share of Fluoxetine Produced by Patheon (FR) in China, 2010-2014 • Chart Sales Value and Market Share of Fluoxetine Produced by Shanghai Zhongxi in China, 2010-2014 • Chart Sales Value and Market Share of Fluoxetine Produced by Changzhou Siyao, 2010-2014 • Chart Sales Value and Market Share of Fluoxetine Produced by other manufacturers in China, 2010-2014
- 8. Charts in report • Chart Sales Value and Market Share of Fluoxetine Tablet in China, 2010-2014 • Chart Sales Value and Market Share of Fluoxetine Capsule in China, 2010-2014 • Chart Sales Price of Fluoxetine Produced by Patheon France (FR) in Some Chinese Cities in 2014 • Chart Sales Price of Fluoxetine Produced by Shanghai Zhongxi Pharmaceutical Co., Ltd. in Some Chinese Cities in 2014 • Chart Sales Price of Fluoxetine Produced by Shanxi C&Y Pharmaceutical Group Co., Ltd. in Some Chinese Cities in 2014
- 9. Charts in report • Chart Sales Price of Fluoxetine Produced by WATSON Pharmaceuticals (Changzhou) Co., Ltd. in Some Chinese Cities in 2014 • Chart Sales Price of Fluoxetine Produced by Changzhou Siyao Pharmaceutical Co., Ltd. in Some Chinese Cities in 2014 • Chart Sales Price of Fluoxetine Produced by Suzhou Chung- Hwa Pharmaceutical & Chemical Industrial Co., Ltd. (SCCPC)in Some Chinese Cities in 2014 • Chart Sales Price of Fluoxetine Produced by Eli Lilly and Company in Some Chinese Cities in 2014
- 10. Contact • To Read more information on the report, its contents and how it could be of value to your company please visit: https://www.marketinforesearch.com/investigation-report- on-china-fluoxetine-market-2010-2019.html If you have any questions about this reports please contact: MarketInfoResearch.com Corp. +91-(22)-6522-3556 info@marketinforesearch.com
- 11. About us MarketInfoResearch.com Corp. specializes in providing comprehensive collection of online market research reports, country reports, company profiles, customized research services offering informative solutions worldwide.